MEDBOTX™
MEDBOTX™ for Personalized Medicines
PharmaTher believes healthcare is moving toward greater personalization, including patient-specific dosing, alternative delivery formats, combination therapies, improved adherence and localized manufacturing. These trends are particularly relevant in settings where conventional mass manufacturing may not address the needs of specific patients, prescribers or clinical workflows.
MEDBOTX™ is designed as a point-of-care and small-batch manufacturing platform that may support personalized dose forms, including polypills, tablets, oral films, gels, suppositories, chews, patches, osmotic-pump formats, and other advanced drug delivery formats. PharmaTher’s initial commercial focus is expected to include personalized medicines, regulated peptide opportunities, compounded pharmaceuticals, and partner-facing formulation and development services.
PharmaTher believes healthcare is moving toward greater personalization, including patient-specific dosing, alternative delivery formats, combination therapies, improved adherence and localized manufacturing. These trends are particularly relevant in settings where conventional mass manufacturing may not address the needs of specific patients, prescribers or clinical workflows.
MEDBOTX™ is designed as a point-of-care and small-batch manufacturing platform that may support personalized dose forms, including polypills, tablets, oral films, gels, suppositories, chews, patches, osmotic-pump formats, and other advanced drug delivery formats. PharmaTher’s initial commercial focus is expected to include personalized medicines, regulated peptide opportunities, compounded pharmaceuticals, and partner-facing formulation and development services.
MEDBOTX™ is designed to support this shift by enabling programmable, flexible and potentially scalable production of personalized medicines and advanced dose formats, which could be relevant for:
- Hospitals and compounding pharmacies, including 503A pharmacies, seeking point-of-care capabilities to support individualized, prescription-based medicines;
- PharmaTher’s internal product pipeline, including custom peptides, psychedelics, and microneedle patch development programs; and
- Specialty pharmaceutical and biotech partners seeking formulation development and small-batch production for clinical studies and commercialization.
© COPYRIGHT 2026. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."